SCHEMBL9867788

SCHEMBL9867788

NCCSCc1cccc2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.71
CYP2C19 P33261 6/20 0.71
CYP2C9 P11712 3/20 0.71
CYP2D6 P10635 4/20 0.58
HPGD P15428 2/20 0.58
ALDH1A1 P00352 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
CYP3A4 P08684 1/20 0.58
HTT P42858 2/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
MCL1 Q07820 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MPO P05164 1/20 0.42
SLC6A4 P31645 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
POLB P06746 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9456743 0.84 CYP1A2 (1.00) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
SCHEMBL7520769 0.77 CYP1A2 (0.77) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
SCHEMBL10957176 0.75 CYP1A2 (0.63) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
SCHEMBL10954298 0.75 CYP1A2 (0.63) CYP1A2CYP2C19CYP2C9CYP2D6SMN1; SMN2
SCHEMBL134400 0.74 CYP1A2 (0.54) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
Hydrochloric Acid SCHEMBL6232539 0.74 CYP1A2 (0.73) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
SCHEMBL29484446 0.73 CYP1A2 (0.58) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
SCHEMBL110689 0.73 CYP1A2 (0.58) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
Hydrochloric Acid SCHEMBL11572335 0.73 CYP1A2 (0.61) CYP1A2CYP2C19CYP2C9CYP2D6HPGD
SCHEMBL10952426 0.73 CYP1A2 (1.00) CYP1A2CYP2C19CYP2C9CYP2D6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed